tPA as marker of thrombosis development after surgical treatment for pancreatic cancer.

被引：0
|
作者：
Gaziev, Umar Muhmadovich
Kit, Oleg Ivanovich
Frantsiyants, Elena Mikhaylovna
Kozlova, Larisa
Mezentsev, Stanislav Stanislavovich
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e15679
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15679
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Gflip/ox in the treatment of advanced pancreatic cancer.
    Hirshaut, Yashar
    Khalil, Daniel
    Kramer, Rachel V.
    Helfgott, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] An evaluation of national treatment trends in pancreatic cancer.
    Seal, Brian S.
    Xia, Fang
    Germino, Rebecca
    Rietschel, Petra
    Asche, Carl V.
    D'Souza, Anna O.
    Morland, Keille
    Eaddy, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Cutaneous angiosarcoma of the breast after conservative surgical and radiotherapy treatment of breast cancer.
    Mohty, AM
    Buffiere, I
    Joujoux, JM
    Carles, MJ
    Guillot, B
    JOURNAL DES MALADIES VASCULAIRES, 2001, 26 (05) : 322 - 324
  • [34] Urinary cyclic GMP after treatment of gynecological cancer.: A prognostic marker of clinical outcome
    Orbo, Anne
    Hanevik, Malfrid
    Jæger, Ragnhild
    Van Heusden, Saskia
    Sager, Georg
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2591 - 2596
  • [35] Marker development for early detection of pancreatic cancer
    Pogue-Geile, K
    George, R
    Crispin, D
    Brentnall, T
    Lyons-Weiler, J
    Whitcomb, D
    GASTROENTEROLOGY, 2004, 126 (04) : A654 - A654
  • [36] Comment on: MicroRNA Expression as a Predictive Marker for Gemcitabine Response After Surgical Resection of Pancreatic Cancer
    Dhayat, Sameer A.
    Mardin, Wolf Arif
    Senninger, Norbert
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S669 - S669
  • [37] Comment on: MicroRNA Expression as a Predictive Marker for Gemcitabine Response After Surgical Resection of Pancreatic Cancer
    Sameer A. Dhayat
    Wolf Arif Mardin
    Norbert Senninger
    Annals of Surgical Oncology, 2017, 24 : 669 - 669
  • [38] Plasma caveolin-1 level: A prognostic marker for pancreatic cancer.
    Demirci, Nebi Serkan
    Dogan, Mutlu
    Erdem, Gokmen Umut
    Kacar, Sabite
    Turhan, Turan
    Yilmaz, Fatma Meric
    Kilickap, Saadettin
    Cigirgan, Lutfi Can
    Kayacetin, Ertugrul
    Zengin, Nurullah
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Outcome measures in a prospective, randomized surgical trial in pancreatic cancer.
    PANCREAS, 2004, 29 (04) : 355 - 355
  • [40] Neutrophil-to-lymphocyte ratio as a prognostic marker for metastatic pancreatic cancer.
    Desai, Jasmin Radhika
    Colton, Bradley Scott
    Wang, Hongkun
    Marshall, John
    Kim, Sunnie S.
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345